INHALABLE PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CORONAVIRUS DISEASE 2019 (COVID-19)
The present invention relates to an inhalable pharmaceutical composition comprising budesonide or formoterol for preventing or treating COVID-19, and the composition exhibits more superb inhibitory effects on the virus than remdesivir injections and ciclesonide inhalations, which are known as therap...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; kor |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to an inhalable pharmaceutical composition comprising budesonide or formoterol for preventing or treating COVID-19, and the composition exhibits more superb inhibitory effects on the virus than remdesivir injections and ciclesonide inhalations, which are known as therapeutic agents for COVID-19.
La présente invention concerne une composition pharmaceutique inhalable comprenant du budésonide ou du formotérol pour la prévention ou le traitement de la COVID-19 et la composition présente des effets encore plus excellents sur l'inhibition virale que les injections de remdésivir et les inhalations de ciclésonide, qui sont connus en tant qu'agents thérapeutiques pour la COVID-19.
본 발명은 부데소니드 및 포르모테롤을 포함하는 코로나 19 예방 또는 치료용 흡입형 약학조성물에 관한 것으로 코로나 19 치료제로 알려진 렘데시비르 주사제제 및 시클레소니드 흡입제보다도 바이러스 억제에 더욱 우수한 효과를 나타낸다. |
---|